Monthly
US$200
Billed every month
Sign in to subscribeOseltamivir Phosphate For Oral Suspension
As of 13 November 2026, for Oseltamivir Phosphate For Oral Suspension, 2 applications are listed as under review at China's CDE; 2 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 49 holders.
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 1 applicationNo longer listed under review: 1 application
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Catalogue holders49View records ↓
Under-review filings2View records ↓
This year’s generic filers2View records ↓
NHSA approval numbers39View records ↓
API companies with A status33View records ↓
Chemical-drug catalogue
Loaded records: 49 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 49 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Ao Mei Pharmaceutical (Hainan) Co., Ltd. romanized | Ao Mei Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20265380 | 2026/07/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangxi Yao Dou Ren He Pharmaceutical Co., Ltd. romanized | Jiangxi Yao Dou Ren He Pharmaceutical Co., Ltd. romanized | 国药准字H20264737 | 2026/06/10 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangzhou Bai Yun Shan Pharmaceuticals Group Co., Ltd. Bai Yun Shan Pharmaceutical Factory romanized | Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20264504 | 2026/05/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Bai Nuo Pharmaceuticals Co., Ltd. romanized | Nanchang Li Jian Pharma Co., Ltd. romanized | 国药准字H20263971 | 2026/04/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Anhui Ji Ren Pharma Co., Ltd. romanized | Anhui Ji Ren Pharma Co., Ltd. romanized | 国药准字H20263028 | 2026/01/05 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | 国药准字H20256273 | 2025/12/16 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | Xin Hua Pharmaceutical (Gao Mi) Co., Ltd. romanized | 国药准字H20256303 | 2025/12/16 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Ha Yao Group Pharmaceutical Liu Factory romanized | Ha Yao Group Technology Center romanized | 国药准字H20255698 | 2025/10/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan Huluwa Pharmaceutical Group Co., Ltd. | Hainan Huluwa Pharmaceutical Group Co., Ltd. | 国药准字H20255455 | 2025/09/09 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Fujian Sheng Min Dong Li Jie Xun Pharma Co., Ltd. romanized | Fujian Sheng Min Dong Li Jie Xun Pharma Co., Ltd. romanized | 国药准字H20254807 | 2025/07/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Heng Chang (Guangzhou) Xin Yao Research Co., Ltd. romanized | Wuhan Hai Te Biopharmaceutical Co., Ltd. romanized | 国药准字H20254584 | 2025/06/17 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Kui Hua Pharma Group (Heng Shui) De Fei Er Co., Ltd. romanized | Kui Hua Pharma Group (Heng Shui) De Fei Er Co., Ltd. romanized | 国药准字H20253868 | 2025/04/15 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. | 国药准字H20253827 | 2025/04/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jinan Tong Lu Pharmaceuticals Technology Development Co., Ltd. romanized | Shanxi Tong Da Pharma Co., Ltd. romanized | 国药准字H20253826 | 2025/04/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hong Yue Technology (Hu Zhou) Co., Ltd. romanized | Shanxi Tong Da Pharma Co., Ltd. romanized | 国药准字H20253829 | 2025/04/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Jia You Pharma Group Co., Ltd. romanized | Wuhan Hai Te Biopharmaceutical Co., Ltd. romanized | 国药准字H20253775 | 2025/04/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guo Yao Group Zhi Jun (Shenzhen) Pharmaceutical Co., Ltd. romanized | Wuhan Hai Te Biopharmaceutical Co., Ltd. romanized | 国药准字H20253530 | 2025/03/04 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20253138 | 2025/01/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Bao Ding Tian Hao Pharmaceutical Co., Ltd. romanized | Tianjin Han Rui Pharma Co., Ltd. romanized | 国药准字H20253060 | 2025/01/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangdong Wan Fang Pharma Technology Co., Ltd. romanized | Bo Rui Pharmaceutical (Suzhou) Co., Ltd. romanized | 国药准字H20249619 | 2024/12/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Si Li An Pharma Co., Ltd. romanized | Beijing Si Li An Pharma Co., Ltd. romanized | 国药准字H20249550 | 2024/12/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| China Resources Sanjiu Medical & Pharmaceutical Co.,Ltd. | Tianjin Han Rui Pharma Co., Ltd. romanized | 国药准字H20249097 | 2024/10/16 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Nuo Tai Ao Sai Nuo Biopharmaceutical Co., Ltd. romanized | Tianjin Han Rui Pharma Co., Ltd. romanized | 国药准字H20244919 | 2024/09/19 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Lang Nuo Pharmaceutical Co., Ltd. romanized | Shandong Lang Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20244903 | 2024/09/19 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H20244748 | 2024/08/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | Shanxi Tong Da Pharma Co., Ltd. romanized | 国药准字H20244434 | 2024/07/09 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20244240 | 2024/06/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Sichuan Zi Ren Pharmaceutical Co., Ltd. romanized | Sichuan Zi Ren Pharmaceutical Co., Ltd. romanized | 国药准字H20244155 | 2024/06/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Xiong Di Pharma Co., Ltd. romanized | Huayi Pharmaceuticals (Anhui) Co., Ltd. | 国药准字H20244141 | 2024/06/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan Si Da Pharmaceutical Co., Ltd. romanized | Tianjin Han Rui Pharma Co., Ltd. romanized | 国药准字H20243816 | 2024/05/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Le Pu Pharmaceutical Technology Co., Ltd. romanized | Le Pu Pharmaceutical Technology Co., Ltd. romanized | 国药准字H20243080 | 2024/01/23 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Haerbin Hua Rui Sheng Hua Pharma Co., Ltd. romanized | Haerbin Hua Rui Sheng Hua Pharma Co., Ltd. romanized | 国药准字H20234622 | 2023/12/13 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Yang Ling Ke Sen Biopharmaceutical Co., Ltd. romanized | Yang Ling Ke Sen Biopharmaceutical Co., Ltd. romanized | 国药准字H20234627 | 2023/12/13 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Amneal Pharmaceuticals of New York, LLC | Amneal Pharmaceuticals of New York, LLC | 国药准字HJ20230112 | 2023/10/12 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | Tianjin Han Rui Pharma Co., Ltd. romanized | 国药准字H20234202 | 2023/09/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20234149 | 2023/09/12 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20233925 | 2023/07/11 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangzhou Nan Xin Pharmaceutical Co., Ltd. romanized | Bo Rui Pharmaceutical (Suzhou) Co., Ltd. romanized | 国药准字H20233623 | 2023/05/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20233375 | 2023/03/24 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Jiang Feng Pharmaceuticals Technology Co., Ltd. romanized | Tianjin Han Rui Pharma Co., Ltd. romanized | 国药准字H20233382 | 2023/03/24 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Qilu Pharmaceutical (Hainan) Co., Ltd | Qilu Pharmaceutical (Hainan) Co., Ltd | 国药准字H20233237 | 2023/02/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Haerbin Shi Kang Long Pharma Co., Ltd. romanized | Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | 国药准字H20223901 | 2022/11/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Suzhou Erye Pharmaceutical Co., Ltd | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20223568 | 2022/08/10 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Bo Rui Pharmaceutical (Suzhou) Co., Ltd. romanized | Bo Rui Pharmaceutical (Suzhou) Co., Ltd. romanized | 国药准字H20223402 | 2022/06/16 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | 国药准字H20223198 | 2022/04/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Yi Chang Dong Yang Guang Chang Jiang Pharma Co., Ltd. romanized | Yi Chang Dong Yang Guang Chang Jiang Pharma Co., Ltd. romanized | 国药准字H20223213 | 2022/04/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H20223147 | 2022/03/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hetero Labs Limited | Hetero Labs Limited | 国药准字HJ20210075 | 2021/10/26 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | 国药准字H20234558 | 2023/11/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 39 distinct approval numbers and 39 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Beijing Si Li An Pharma Co., Ltd. romanized | 国药准字H20249550 | See source | Category B | XJ05AHA218X006010100011 | NHSA |
| Guangzhou Nan Xin Pharmaceutical Co., Ltd. romanized | 国药准字H20233623 | See source | Category B | XJ05AHA218X006010100407 | NHSA |
| China Resources Sanjiu Medical & Pharmaceutical Co.,Ltd. | 国药准字H20249097 | See source | Category B | XJ05AHA218X006010100474 | NHSA |
| Guo Yao Group Zhi Jun (Shenzhen) Pharmaceutical Co., Ltd. romanized | 国药准字H20253530 | See source | Category B | XJ05AHA218X006010100555 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20234149 | See source | Category B | XJ05AHA218X006010101503 | NHSA |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H20244748 | See source | Category B | XJ05AHA218X006010101522 | NHSA |
| Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20223568 | See source | Category B | XJ05AHA218X006010101651 | NHSA |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H20223147 | See source | Category B | XJ05AHA218X006010102013 | NHSA |
| Sichuan Zi Ren Pharmaceutical Co., Ltd. romanized | 国药准字H20244155 | See source | Category B | XJ05AHA218X006010102277 | NHSA |
| Yang Ling Ke Sen Biopharmaceutical Co., Ltd. romanized | 国药准字H20234627 | See source | Category B | XJ05AHA218X006010102544 | NHSA |
| Bao Ding Tian Hao Pharmaceutical Co., Ltd. romanized | 国药准字H20253060 | See source | Category B | XJ05AHA218X006010102551 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20233925 | See source | Category B | XJ05AHA218X006010102763 | NHSA |
| Sui Cheng Pharma Co., Ltd. romanized | 国药准字H20253902 | See source | Category B | XJ05AHA218X006010103204 | NHSA |
| Haerbin Hua Rui Sheng Hua Pharma Co., Ltd. romanized | 国药准字H20234622 | See source | Category B | XJ05AHA218X006010103634 | NHSA |
| Ha Yao Group Pharmaceutical Liu Factory romanized | 国药准字H20255698 | See source | Category B | XJ05AHA218X006010103710 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20256303 | See source | Category B | XJ05AHA218X006010104187 | NHSA |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | 国药准字H20256273 | See source | Category B | XJ05AHA218X006010104685 | NHSA |
| Fujian Sheng Min Dong Li Jie Xun Pharma Co., Ltd. romanized | 国药准字H20254807 | See source | Category B | XJ05AHA218X006010104799 | NHSA |
| Hainan Huluwa Pharmaceutical Group Co., Ltd. | 国药准字H20255455 | See source | Category B | XJ05AHA218X006010105789 | NHSA |
| Hainan Si Da Pharmaceutical Co., Ltd. romanized | 国药准字H20243816 | See source | Category B | XJ05AHA218X006010105816 | NHSA |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20233237 | See source | Category B | XJ05AHA218X006010105847 | NHSA |
| Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | 国药准字H20223198 | See source | Category B | XJ05AHA218X006010106988 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20233375 | See source | Category B | XJ05AHA218X006010109920 | NHSA |
| Hetero Labs Limited | 国药准字HJ20210075 | See source | Category B | XJ05AHA218X006010179426 | NHSA |
| Bo Rui Pharmaceutical (Suzhou) Co., Ltd. romanized | 国药准字H20223402 | See source | Category B | XJ05AHA218X006010180081 | NHSA |
| Haerbin Shi Kang Long Pharma Co., Ltd. romanized | 国药准字H20223901 | See source | Category B | XJ05AHA218X006010180537 | NHSA |
| Jiangsu Nuo Tai Ao Sai Nuo Biopharmaceutical Co., Ltd. romanized | 国药准字H20244919 | See source | Category B | XJ05AHA218X006010180539 | NHSA |
| Yi Chang Dong Yang Guang Chang Jiang Pharma Co., Ltd. romanized | 国药准字H20223213 | See source | Category B | XJ05AHA218X006010180955 | NHSA |
| Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | 国药准字H20234558 | See source | Category B | XJ05AHA218X006010182209 | NHSA |
| Le Pu Pharmaceutical Technology Co., Ltd. romanized | 国药准字H20243080 | See source | Category B | XJ05AHA218X006010182919 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20244240 | See source | Category B | XJ05AHA218X006010182922 | NHSA |
| Shandong Bai Nuo Pharmaceuticals Co., Ltd. romanized | 国药准字H20263971 | See source | Category B | XJ05AHA218X006010183011 | NHSA |
| Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized | 国药准字H20253138 | See source | Category B | XJ05AHA218X006010183544 | NHSA |
| Heng Chang (Guangzhou) Xin Yao Research Co., Ltd. romanized | 国药准字H20254584 | See source | Category B | XJ05AHA218X006010183569 | NHSA |
| Jiangsu Jiang Feng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20233382 | See source | Category B | XJ05AHA218X006010183817 | NHSA |
| Shanxi Tong Da Pharma Co., Ltd. romanized | 国药准字H20253829 | See source | Category B | XJ05AHA218X006010184219 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244434 | See source | Category B | XJ05AHA218X006010184221 | NHSA |
| Jiangsu Jia You Pharma Group Co., Ltd. romanized | 国药准字H20253775 | See source | Category B | XJ05AHA218X006010184962 | NHSA |
| Jinan Tong Lu Pharmaceuticals Technology Development Co., Ltd. romanized | 国药准字H20253826 | See source | Category B | XJ05AHA218X006010185067 | NHSA |
| Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20223568 | See source | Category B | XJ05AHA218X006010201651 | NHSA |
| Sichuan Zi Ren Pharmaceutical Co., Ltd. romanized | 国药准字H20244155 | See source | Category B | XJ05AHA218X006010202277 | NHSA |
| Hetero Labs Limited | 国药准字HJ20210075 | See source | Category B | XJ05AHA218X006010279426 | NHSA |
| Shanxi Tong Da Pharma Co., Ltd. romanized | 国药准字H20253829 | See source | Category B | XJ05AHA218X006010284219 | NHSA |
| Shanxi Tong Da Pharma Co., Ltd. romanized | 国药准字H20253829 | See source | Category B | XJ05AHA218X006010384219 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 2 filings and 2 distinct first applicants.
Generic 2
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Hebei Hua Chen Pharma Group Co., Ltd. romanized | CYHS2602206 | Generic | 2026/09/04 | Not stated by source | CDE |
| Jilin Sheng Wu Tai Gan Kang Pharma Co., Ltd. romanized | CYHS2600227 | Generic | 2026/01/20 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 2 filings and 2 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Hebei Hua Chen Pharma Group Co., Ltd. romanized | CYHS2602206 | Generic | 2026/09/04 | Not stated by source | CDE |
| Jilin Sheng Wu Tai Gan Kang Pharma Co., Ltd. romanized | CYHS2600227 | Generic | 2026/01/20 | Not stated by source | CDE |
API registrations
Non-component matches: 33 companies with A status and 5 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 磷酸奥司他韦 · No verified English name | Bai Yun Shandong Tai Shang Qiu Pharma Co., Ltd. romanized | Y20260000131 | I | Exact ingredient | 2026/03/20 | CDE |
| 磷酸奥司他韦 · No verified English name | Jilin Ao Dong Tao Nan Pharma Co., Ltd. romanized | Y20250001476 | I | Exact ingredient | 2026/01/09 | CDE |
| 磷酸奥司他韦 · No verified English name | Xin Tian Di Pharma Co., Ltd. romanized | Y20250001153 | I | Exact ingredient | 2025/11/07 | CDE |
| 磷酸奥司他韦 · No verified English name | Hebei Hua Chen Pharma Group Co., Ltd. romanized | Y20240001127 | A | Exact ingredient | 2026/03/16 | CDE |
| 磷酸奥司他韦 · No verified English name | Xin Xiang Shuang Lu Pharma Co., Ltd. romanized | Y20240000651 | A | Exact ingredient | 2026/05/07 | CDE |
| 磷酸奥司他韦 · No verified English name | Wan Yang Heng Shui Pharmaceutical Co., Ltd. romanized | Y20240000564 | A | Exact ingredient | 2026/09/29 | CDE |
| 磷酸奥司他韦 · No verified English name | Zhuhai Hai Rui De Pharmaceutical Co., Ltd. romanized | Y20240000421 | A | Exact ingredient | 2026/01/07 | CDE |
| 磷酸奥司他韦 · No verified English name | Shenzhen Shi Hai Bin Pharmaceutical Co., Ltd. romanized | Y20240000379 | A | Exact ingredient | 2026/04/01 | CDE |
| 磷酸奥司他韦 · No verified English name | ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | Y20230000607 | A | Exact ingredient | 2025/02/07 | CDE |
| 磷酸奥司他韦 · No verified English name | Sui Cheng Pharma Co., Ltd. romanized | Y20230000528 | A | Exact ingredient | 2024/09/30 | CDE |
| 磷酸奥司他韦 · No verified English name | Ru Yuan Dong Yang Guang Pharma Co., Ltd. romanized | Y20230000225 | A | Exact ingredient | 2025/12/05 | CDE |
| 磷酸奥司他韦 · No verified English name | Fujian Sheng Fu Kang Pharma Co., Ltd. romanized | Y20230000154 | A | Exact ingredient | 2025/10/16 | CDE |
| 磷酸奥司他韦 · No verified English name | Beijing Jin Cheng Tai Er Pharmaceutical Co., Ltd. romanized | Y20220001282 | A | Exact ingredient | 2025/07/23 | CDE |
| 磷酸奥司他韦 · No verified English name | Sui Cheng Pharma Co., Ltd. romanized | Y20220001053 | I | Exact ingredient | 2023/04/25 | CDE |
| 磷酸奥司他韦 · No verified English name | Suzhou Zheng Ji Pharma Co., Ltd. romanized | Y20220000844 | A | Exact ingredient | 2025/03/05 | CDE |
| 磷酸奥司他韦 · No verified English name | Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | Y20220000876 | A | Exact ingredient | 2025/07/28 | CDE |
| 磷酸奥司他韦 · No verified English name | Topfond Pharmaceutical Co., Ltd. | Y20220000727 | A | Exact ingredient | 2026/05/20 | CDE |
| 磷酸奥司他韦 · No verified English name | Hunan Ou Ya Pharma Co., Ltd. romanized | Y20220000508 | A | Exact ingredient | 2025/09/11 | CDE |
| 磷酸奥司他韦 · No verified English name | Hai Zheng Pharma Nan Tong Co., Ltd. romanized | Y20220000102 | A | Exact ingredient | 2024/02/28 | CDE |
| 磷酸奥司他韦 · No verified English name | Hangzhou Fu Si Te Pharma Co., Ltd. romanized | Y20220000223 | A | Exact ingredient | 2024/05/21 | CDE |
| 磷酸奥司他韦 · No verified English name | Chongqing Rui Po Lai Pharmaceutical Co., Ltd. romanized | Y20220000017 | A | Exact ingredient | 2025/03/11 | CDE |
| 磷酸奥司他韦 · No verified English name | INIST ST Co., Ltd. | Y20210001077 | A | Exact ingredient | 2024/03/25 | CDE |
| 磷酸奥司他韦 · No verified English name | Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | Y20210000702 | A | Exact ingredient | 2025/12/17 | CDE |
| 磷酸奥司他韦 · No verified English name | SOLARA ACTIVE PHARMA SCIENCES LIMITED | Y20210000504 | A | Exact ingredient | 2024/02/08 | CDE |
| 磷酸奥司他韦 · No verified English name | Innovare Labs Private Limited | Y20210000432 | A | Exact ingredient | 2023/08/01 | CDE |
| 磷酸奥司他韦 · No verified English name | Hunan Jiu Dian Hong Yang Pharmaceutical Co., Ltd. romanized | Y20210000419 | A | Exact ingredient | 2025/01/11 | CDE |
| 磷酸奥司他韦 · No verified English name | Nanjing Hai Jing Pharma Co., Ltd. romanized | Y20210000418 | A | Exact ingredient | 2024/03/26 | CDE |
| 磷酸奥司他韦 · No verified English name | Shanghai Di Sai Nuo Chemical Pharmaceutical Co., Ltd. romanized | Y20210000082 | A | Exact ingredient | 2024/04/12 | CDE |
| 磷酸奥司他韦 · No verified English name | Zhongshan Wanhan Pharmaceuticals Co., Ltd. | Y20200001194 | A | Exact ingredient | 2024/10/31 | CDE |
| 磷酸奥司他韦 · No verified English name | Yang Ling Ji Tai Pharma Co., Ltd. romanized | Y20200000789 | A | Exact ingredient | 2023/03/24 | CDE |
| 磷酸奥司他韦 · No verified English name | Jiangsu Nuo Tai Ao Sai Nuo Biopharmaceutical Co., Ltd. romanized | Y20200000736 | A | Exact ingredient | 2026/10/11 | CDE |
| 磷酸奥司他韦 · No verified English name | Matrix Pharmacorp Private Limited | Y20200000772 | A | Exact ingredient | 2026/08/22 | CDE |
| 磷酸奥司他韦 · No verified English name | Laurus Labs Limited | Y20190000837 | A | Exact ingredient | 2024/07/18 | CDE |
| 磷酸奥司他韦 · No verified English name | Yi Chang Dong Yang Guang Chang Jiang Pharma Co., Ltd. romanized | Y20190009757 | A | Exact ingredient | 2023/03/24 | CDE |
| 磷酸奥司他韦 · No verified English name | Bo Rui Pharmaceutical (Suzhou) Co., Ltd. romanized | Y20180001370 | A | Exact ingredient | 2026/05/08 | CDE |
| 磷酸奥司他韦 · No verified English name | MSN Pharmachem Private Limited | Y20190000398 | A | Exact ingredient | 2026/05/20 | CDE |
| 磷酸奥司他韦 · No verified English name | Raks Pharma Pvt.Ltd. | Y20190000606 | I | Exact ingredient | 2019/08/14 | CDE |
| 磷酸奥司他韦 · No verified English name | Hetero Labs Limited | Y20180001225 | A | Exact ingredient | 2026/10/12 | CDE |
| 磷酸奥司他韦 · No verified English name | Yi Chang Dong Yang Guang Chang Jiang Pharma Co., Ltd. romanized | Y20170001954 | A | Exact ingredient | 2026/08/07 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
-
2026/10/30No longer listed under review
Yi Chang Ren Fu Pharma Co., Ltd. romanized
CYHS2500067
Fact date: 2026/10/30 · Site observation date: 2026/10/30
Accepted: 2025/01/06
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/09/04Accepted
Hebei Hua Chen Pharma Group Co., Ltd. romanized
CYHS2602206
Fact date: 2026/09/04 · Site observation date: 2026/10/22
View source ↗
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/13 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/13 06:39
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/13 06:41
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/13 08:09 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Oseltamivir Phosphate For Oral Suspension
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy